Lessons From the EThIGII Trial: Proper Putative Benefit Assessment of Low- Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers
Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ
Research article (journal) | Peer reviewedDetails about the publication
Journal: Clinical and Applied Thrombosis/Hemostasis
Volume: 2016
Status: online first
Release year: 2016 (14/07/2016)
Language in which the publication is written: English
Authors from the University of Münster
| Markov, Arseni |